Although iASPP deletion promoted a tolerogenic tumor microenvironment in lung and pancreatic tumors, the cell-intrinsic oncogenic properties of iASPP might dominate in other cancer types with less significant immunosurveillance. The gene discussed is PPP1R13L; the disease is cancer.